JP2013514980A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013514980A5 JP2013514980A5 JP2012544854A JP2012544854A JP2013514980A5 JP 2013514980 A5 JP2013514980 A5 JP 2013514980A5 JP 2012544854 A JP2012544854 A JP 2012544854A JP 2012544854 A JP2012544854 A JP 2012544854A JP 2013514980 A5 JP2013514980 A5 JP 2013514980A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- group
- pharmaceutically acceptable
- acceptable salt
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 14
- 229910052760 oxygen Inorganic materials 0.000 claims 9
- 229910052799 carbon Inorganic materials 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000002723 alicyclic group Chemical group 0.000 claims 3
- 102000019355 Synuclein Human genes 0.000 claims 2
- 108050006783 Synuclein Proteins 0.000 claims 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000001165 hydrophobic group Chemical group 0.000 claims 2
- 206010012289 Dementia Diseases 0.000 claims 1
- 201000010374 Down Syndrome Diseases 0.000 claims 1
- 201000011240 Frontotemporal dementia Diseases 0.000 claims 1
- 208000009829 Lewy Body Disease Diseases 0.000 claims 1
- 201000002832 Lewy body dementia Diseases 0.000 claims 1
- 208000001089 Multiple system atrophy Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 claims 1
- 229910005965 SO 2 Inorganic materials 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 0 CC(*)(*N)NN Chemical compound CC(*)(*N)NN 0.000 description 3
- JYXUDLCIDLRXEP-UHFFFAOYSA-N CC1=NC2=CCCC=C2N1 Chemical compound CC1=NC2=CCCC=C2N1 JYXUDLCIDLRXEP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28708209P | 2009-12-16 | 2009-12-16 | |
| US61/287,082 | 2009-12-16 | ||
| PCT/US2010/060862 WO2011084642A1 (en) | 2009-12-16 | 2010-12-16 | Compound suitable for the treatment of synucleopathies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015218140A Division JP2016074679A (ja) | 2009-12-16 | 2015-11-06 | 化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013514980A JP2013514980A (ja) | 2013-05-02 |
| JP2013514980A5 true JP2013514980A5 (enExample) | 2014-02-13 |
| JP5922031B2 JP5922031B2 (ja) | 2016-05-24 |
Family
ID=43629477
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012544854A Expired - Fee Related JP5922031B2 (ja) | 2009-12-16 | 2010-12-16 | 化合物 |
| JP2015218140A Withdrawn JP2016074679A (ja) | 2009-12-16 | 2015-11-06 | 化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015218140A Withdrawn JP2016074679A (ja) | 2009-12-16 | 2015-11-06 | 化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8846682B2 (enExample) |
| EP (1) | EP2513090A1 (enExample) |
| JP (2) | JP5922031B2 (enExample) |
| KR (1) | KR20120112548A (enExample) |
| CN (1) | CN102725284A (enExample) |
| AU (1) | AU2010339841B2 (enExample) |
| BR (1) | BR112012014807A2 (enExample) |
| CA (1) | CA2784744A1 (enExample) |
| MX (1) | MX335989B (enExample) |
| NZ (1) | NZ600449A (enExample) |
| RU (1) | RU2012129882A (enExample) |
| WO (1) | WO2011084642A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6159388B2 (ja) | 2012-03-28 | 2017-07-05 | ニューロポア セラピーズ，インコーポレイティド | タンパク質凝集の阻害剤としてのフェニル−尿素及びフェニル−カルバメート誘導体 |
| ES2661394T3 (es) | 2012-07-16 | 2018-03-28 | Neuropore Therapies, Inc. | Derivados de di- y tri-heteroarilo como inhibidores de la agregación de proteínas |
| WO2014179303A1 (en) * | 2013-04-29 | 2014-11-06 | The General Hospital Corporation | Amyloid precursor protein mrna blockers for treating down syndrome and alzheimer's disease |
| PL3348556T3 (pl) * | 2014-01-29 | 2020-11-02 | UCB Biopharma SRL | Heteroaryloamidy jako inhibitory agregacji białka |
| CN104530013B (zh) * | 2014-12-04 | 2016-06-29 | 中国农业大学 | 基于吲哚环的吡唑酰胺类化合物作为农用杀菌剂的用途 |
| EP3328379B1 (en) * | 2015-07-29 | 2021-07-28 | UCB Biopharma SRL | Bis-heteroaryl derivatives as modulators of protein aggregation |
| US10889584B2 (en) * | 2017-01-26 | 2021-01-12 | UCB Biopharma SRL | Bicyclic bis-heteroaryl derivatives as modulators of protein aggregation |
| EA201991753A1 (ru) * | 2017-01-26 | 2020-01-14 | Юсб Байофарма Спрл | Алкоксибисгетероарильные производные в качестве модуляторов агрегации белков |
| MX2019007053A (es) * | 2017-01-26 | 2019-08-29 | Ucb Biopharma Sprl | Derivados de bis-heteroarilo como moduladores de la agregacion de proteinas. |
| EP3634407A1 (en) | 2017-05-11 | 2020-04-15 | Remynd N.V. | Inhibitors of pde6delta for use in the prevention and/or treatment of epilepsy and/or neurodegenerative disorders |
| DK3621963T3 (da) | 2017-05-11 | 2024-04-15 | Remynd N V | Forbindelser til behandling af epilepsi, neurodegenerative lidelser og andre CNS-lidelser |
| EP4458824A4 (en) * | 2021-12-27 | 2025-12-24 | Shanghai Jingxin Biomedical Co Ltd | Fused bicyclic heteroarylamide compound useful as a protein aggregation inhibitor |
| TW202415651A (zh) | 2022-07-29 | 2024-04-16 | 日商住友製藥股份有限公司 | 含氮飽和雜環衍生物 |
| TW202412787A (zh) | 2022-07-29 | 2024-04-01 | 日商住友製藥股份有限公司 | 2(1h)-吡啶亞胺衍生物 |
| WO2024102758A2 (en) * | 2022-11-08 | 2024-05-16 | The General Hospital Corporation | N-(n-aminoalkyl)phenanthridiunium series of chloride-sensitive fluorophores and methods of use thereof |
| CN121487929A (zh) * | 2023-06-25 | 2026-02-06 | 上海京新生物医药有限公司 | 双环杂芳基酰胺化合物的晶型及盐、制备方法和用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0726263A3 (en) * | 1995-02-08 | 1996-10-09 | American Cyanamid Co | Herbicides (1,3,4) oxadiazoles and thiadiazoles |
| US5591695A (en) * | 1995-02-08 | 1997-01-07 | American Cyanamid Co. | Herbicidal [1,3,4]oxadiazoles and thiadiazoles |
| WO1998027108A2 (en) * | 1996-12-16 | 1998-06-25 | Fujisawa Pharmaceutical Co., Ltd. | New amide compounds and their use as nitric oxide synthase inhibitors |
| US6096688A (en) * | 1996-12-27 | 2000-08-01 | American Cyanamid Company | Oxazole carboxamide herbicides |
| WO2005074642A2 (en) * | 2004-01-30 | 2005-08-18 | Smithkline Beecham Corporation | Chemical compounds |
| NZ588432A (en) * | 2004-09-17 | 2012-03-30 | Whitehead Biomedical Inst | Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity |
| DE102004051277A1 (de) | 2004-10-21 | 2006-04-27 | Merck Patent Gmbh | Heterocyclische Carbonylverbindungen |
| KR101394245B1 (ko) * | 2005-12-30 | 2014-05-14 | 에스케이바이오팜 주식회사 | 아이속사졸 유도체 및 이의 용도 |
| US8541406B2 (en) * | 2006-02-07 | 2013-09-24 | Nv Remynd | Thiadiazole derivatives for the treatment of neurodegenerative diseases |
| EP2007373A4 (en) * | 2006-03-29 | 2012-12-19 | Foldrx Pharmaceuticals Inc | INHIBITION OF ALPHA SYNUCLEINE TOXICITY |
| JP2011518188A (ja) * | 2008-04-18 | 2011-06-23 | ユニバーシティ オブ コネチカット | リソソーム調節のための化合物および使用方法 |
| GB0910003D0 (en) | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
-
2010
- 2010-12-16 WO PCT/US2010/060862 patent/WO2011084642A1/en not_active Ceased
- 2010-12-16 AU AU2010339841A patent/AU2010339841B2/en not_active Ceased
- 2010-12-16 CA CA2784744A patent/CA2784744A1/en not_active Abandoned
- 2010-12-16 US US13/516,543 patent/US8846682B2/en active Active
- 2010-12-16 BR BR112012014807A patent/BR112012014807A2/pt not_active IP Right Cessation
- 2010-12-16 KR KR1020127018232A patent/KR20120112548A/ko not_active Ceased
- 2010-12-16 EP EP10805668A patent/EP2513090A1/en not_active Withdrawn
- 2010-12-16 RU RU2012129882/04A patent/RU2012129882A/ru not_active Application Discontinuation
- 2010-12-16 MX MX2012006740A patent/MX335989B/es unknown
- 2010-12-16 JP JP2012544854A patent/JP5922031B2/ja not_active Expired - Fee Related
- 2010-12-16 NZ NZ600449A patent/NZ600449A/en not_active IP Right Cessation
- 2010-12-16 CN CN2010800568024A patent/CN102725284A/zh active Pending
-
2014
- 2014-08-21 US US14/465,773 patent/US20140364610A1/en not_active Abandoned
-
2015
- 2015-11-06 JP JP2015218140A patent/JP2016074679A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013510120A5 (enExample) | ||
| JP2014500861A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| JP2013542247A5 (enExample) | ||
| JP2010524932A5 (enExample) | ||
| JP2013510178A5 (enExample) | ||
| JP2009504764A5 (enExample) | ||
| JP2010138190A5 (enExample) | ||
| JP2013544276A5 (enExample) | ||
| JP2006524660A5 (enExample) | ||
| JP2015520140A5 (enExample) | ||
| JP2012513416A5 (enExample) | ||
| JP2011507896A5 (enExample) | ||
| JP2014508804A5 (enExample) | ||
| WO2009095872A3 (en) | Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors | |
| JP2012526808A5 (enExample) | ||
| PH12013501442B1 (en) | Immunosuppressant formulations | |
| JP2012512863A5 (enExample) | ||
| JP2013542981A5 (enExample) | ||
| JP2015509075A5 (enExample) | ||
| JP2011509302A5 (enExample) | ||
| JP2015535847A5 (enExample) | ||
| JP2003503449A5 (enExample) | ||
| JP2013518036A5 (enExample) | ||
| JP2013514974A5 (enExample) |